Basel Medical (BMGL) EBIT (2023 - 2024)

Basel Medical recorded quarterly EBIT of -$164657.1 in Q4 2024, down 112.07% quarter-over-quarter from $1.4 million in Q4 2023, and down 112.07% year-over-year from $1.4 million in Q1 2024.

Basel Medical's EBIT history runs 2 years deep, the most recent figure standing at -$164657.1 for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -566.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 1.30 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 481.89 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 59.70 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 124.85 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 502.86 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 2.13 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 84.58 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 120.04 Mn
10 Basel Medical 8.57 Mn 6.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -164,657.08
Dec 31, 2023 1.36 Mn